Olema Pharmaceuticals, Inc. (OLMA)

NMS – Real Time Price. Currency in USD

10.49

+0.06 (0.58%)

Market open: Aug 12, 2026, 3:45 PM EDT

10.44

+0.01 (0.10%)

Previous after-hours: Aug 11, 2026, 7:36 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

Cost of goods sold

-490K

-393K

-377K

-2M

Gross Profit

-490K

-393K

-377K

-2M

Operating expenses (excl. COGS)

-178M

-142M

-105M

Operating Income

-179M

-142M

-105M

-107M

Non-operating income, total

16M

13M

Pretax income

-162M

-129M

-97M

-105M

Equity in earnings

Taxes

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-162M

-129M

-97M

-105M

Discontinued operations

Net income

-162M

-129M

-97M

-105M

Dilution adjustment

Preferred dividends

Olema Pharmaceuticals, Inc. (OLMA)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Olema Pharmaceuticals, Inc. (OLMA)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Olema Pharmaceuticals, Inc. (OLMA)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Olema Pharmaceuticals, Inc. (OLMA)

Income Statement (Annual)

Income Statement (Annual)